Bharat Seats Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
BHARATSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.6 pts less than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bharat Seats Limited reported audited financial results for FY 2025-26 with an unqualified audit opinion from S.R. Batliboi & Co. LLP. The Board approved capital expenditure of Rs. 86.61 crores for new Maruti Suzuki programmes at Kharkhoda and Gujarat Navyani plants. A dividend of Rs. 1.50 per share (75%) has been recommended, subject to shareholder approval at the 39th AGM on July 24, 2026 (record date July 17, 2026). The auditors issued an Emphasis of Matter regarding an Income Tax Department search under Section 132 conducted at company premises and residences of key personnel in an earlier year, though the opinion remains unmodified. Mr. Rishabh Relan, son of Chairman & MD Mr. Rohit Relan, has been recommended for re-appointment as Whole Time Director for another 3-year term.
The clean audit provides assurance on financials, though the IT search matter creates some uncertainty around potential tax liabilities. The Rs. 86.61 crore capex commitment for Maruti programmes signals healthy business outlook, while the 75% dividend payout reflects a strong financial position.